Now Ollie is making history as the world’s first successful gene therapy patient for this cruel condition. Ten months after ...
Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.
In addition to being the third consecutive supermoon of the year, as reported by EarthSky, it will be about 357,000 km away ...
The first child in history has successfully been treated with a new genetic therapy for an ultra-rare developmental defect ...
New postmarketing reports link Adzynma to neutralizing antibodies and a fatality, leading the FDA to evaluate the need for updated labeling.
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...
As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, ...
Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
About 40 million people worldwide are living with HIV infection. In the United Kingdom, there are approximately 100,000 people affected. If the infection is not treated, the body will eventually be ...
Denali's validated platform, strategic pipeline, and experienced management present a compelling long-term investment opportunity. Find out why DNLI stock is a Buy.
Two years ago, he was diagnosed with a terminal illness called Batten disease -- often leading to blindness, seizures, and ...
An enzyme found in papaya could lead to new medicines: a scientific review reveals the surprising pharmaceutical potential of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback